Search

Nektar Therapeutics

Closed

60.33 5.4

Overview

Share price change

24h

Current

Min

56.73

Max

61.16

Key metrics

By Trading Economics

Income

4.3M

-41M

Sales

-730K

10M

EPS

-1.23

Profit margin

-400.967

Employees

63

EBITDA

-5.5M

-42M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+143.85% upside

Dividends

By Acuity

Next Earnings

5 Nov 2026

Market Stats

By TradingEconomics

Market Cap

-247M

2.3B

Previous open

54.93

Previous close

60.33

Nektar Therapeutics Chart

Past performance is not a reliable indicator of future results.

Related News

28 Sept 2026, 23:56 UTC

Scotts Miracle-Gro Co is down in after-market hours, marking a fifth consecutive session of lower performance and remaining below its 20-day moving average.

28 Sept 2026, 23:56 UTC

Correlated Moves

BILL Holdings Inc trades modestly higher in after-market hours, supported by positive momentum in Gen Digital Inc following optimistic comments on its fiscal 2027 outlook.

28 Sept 2026, 23:56 UTC

Correlated Moves

Pinnacle West Capital Corp traded modestly higher in after-market hours, maintaining a steady return since Monday's close, despite broader market conditions.

28 Sept 2026, 23:56 UTC

Patterson-UTI Energy Inc is gaining modestly in after-market trading, continuing a routine move since Monday's close while remaining below its 20-day moving average.

28 Sept 2026, 23:55 UTC

Gray Media Inc has advanced modestly in after-market trading, reflecting a shift in momentum despite remaining below its 20-day moving average.

28 Sept 2026, 23:55 UTC

Voya Financial Inc is trading lower in after-market hours, remaining near the low end of its one-month range and below its 20-day moving average.

28 Sept 2026, 23:55 UTC

Global Net Lease Inc is trading modestly higher in after-market hours, reflecting stronger performance compared to the previous seven sessions that all ended lower.

28 Sept 2026, 23:55 UTC

News

Neurocrine Biosciences shares rise in after-market trading following the return of Eiry W. Roberts, M.D., as Chief Medical Officer, ensuring continuity for late-stage programs.

28 Sept 2026, 23:55 UTC

Emerson Electric Co is trading modestly higher in after-market hours, significantly above its 20-day moving average and showing notable upward movement since Monday's close.

28 Sept 2026, 23:55 UTC

Huntington Bancshares Inc is trading modestly higher in after-market hours, stabilizing above earlier session lows while remaining below its 20-day moving average.

28 Sept 2026, 23:55 UTC

F5 Inc's shares are trading modestly lower in after-market hours, continuing a downward trend that has persisted for five consecutive sessions.

28 Sept 2026, 23:55 UTC

Xenon Pharmaceuticals Inc. is trading lower in after-hours, shifting from a slight gain to a more substantial loss since Monday's close, remaining below its 20-day moving average.

28 Sept 2026, 23:55 UTC

CMS Energy Corp is trading modestly higher in after-market hours, recovering from a low point immediately after the regular session close.

28 Sept 2026, 23:55 UTC

APA Corp's shares advanced modestly in after-market trading, stabilizing after earlier gains but remaining below the 20-day moving average.

28 Sept 2026, 23:51 UTC

Novavax Inc. traded modestly higher during after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

28 Sept 2026, 23:51 UTC

Leonardo DRS Inc is trading modestly higher in after-market hours, rebounding from an earlier session low and showing unusual strength compared to typical patterns.

28 Sept 2026, 23:51 UTC

News

ACADIA Pharmaceuticals shares declined in after-market hours despite the allowance of a U.S. patent for weight-banded dosing of trofinetide, extending protections until March 2041.

28 Sept 2026, 23:51 UTC

In after-market trading, MercadoLibre Inc is rising following four sessions of decline, amid significant gains in the Broadline Retail sub-sector.

28 Sept 2026, 23:51 UTC

Peloton Interactive Inc is declining in after-market trading, hitting its lowest point of the day and remaining below its 20-day moving average.

28 Sept 2026, 23:51 UTC

EHang Holdings Ltd is rising in after-market trading, gaining ground after five consecutive lower sessions, despite remaining below its 20-day moving average.

28 Sept 2026, 23:51 UTC

CF Industries Holdings Inc saw a modest decline in after-market trading, remaining near the lower end of its one-month range and below its 20-day moving average.

28 Sept 2026, 23:51 UTC

Affiliated Managers Group Inc is trading lower in after-market hours, continuing a decline since Monday's close despite earlier gains during the session.

28 Sept 2026, 23:51 UTC

Qfin Holdings Inc saw a notable rise in after-market trading, advancing sharply following eight consecutive lower daily finishes, though still below its 20-day moving average.

28 Sept 2026, 23:51 UTC

News

Prospect Capital Corp shares are trading higher in after-market hours following a cash distribution announcement of $0.56232 per share from its fund.

28 Sept 2026, 23:51 UTC

Block Inc declined in after-market hours, continuing a trend of lower closes amid broader market weakness and trading significantly below its 20-day moving average.

28 Sept 2026, 23:51 UTC

Australia's Balance of Trade report on October 1 is expected to show a AUD 2.1 billion surplus, reflecting strong resource exports amid cautious market optimism and global inflation concerns.

28 Sept 2026, 23:51 UTC

JOLTs Job Openings Data Release on September 29 Expected to Show Decline Amid Rising Inflation Fears and Geopolitical Tensions, Influencing Fed Rate Hike Speculations.

28 Sept 2026, 23:51 UTC

US Initial Jobless Claims Expected at 200K, Indicating Labor Market Resilience Amid Inflation Concerns

28 Sept 2026, 23:51 UTC

News

Boston Scientific Corp. has secured a contract worth up to $135.7 million from the U.S. Department of Defense, while shares have moved modestly lower in after-market trading.

28 Sept 2026, 23:51 UTC

Molson Coors Beverage Co's shares traded modestly higher in after-market hours on Monday, despite fluctuations and positioning below the 20-day moving average.

Peer Comparison

Price change

Nektar Therapeutics Forecast

Price Target

By TipRanks

143.85% upside

12 Months Forecast

Average 139.143 USD  143.85%

High 192 USD

Low 50 USD

Based on 9 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

7

Buy

2

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$